Angiotensin-II Blockade in Mitral Regurgitation

NCT00587470 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Mitral Regurgitation

Interventions

DRUG: Candesartan
DRUG: atacand
DRUG: Placebo

Sponsor

Mayo Clinic